Trial Profile
Sustainable Healthcenter Implementation PrEP Pilot Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- Acronyms SHIPP
- 11 Mar 2020 Results presented at the 27th Conference on Retroviruses and Opportunistic Infections
- 26 Jul 2017 Results presented at the 9th International AIDS Society Conference on HIV Science
- 26 Jul 2017 Status changed from recruiting to active, no longer recruiting as per results presented at the 9th International AIDS Society Conference on HIV Science